Journal of Urban Health

, Volume 83, Issue 1, pp 18–30 | Cite as

Integrating HIV Prevention Activities into the HIV Medical Care Setting: A Report from the NYC HIV Centers Consortium

  • Tracey E. WilsonEmail author
  • David Vlahov
  • Stephen Crystal
  • Judith Absalon
  • Susan J. Klein
  • Robert H. Remein
  • Bruce Agins
HIV Perspectives After 25 Years


With the maturing of the HIV epidemic and availability of potent antiretroviral therapies in the US, priorities for HIV prevention have shifted from general population approaches to case finding, treatment, risk reduction and relapse prevention activities among those at greatest risk for acquiring or transmitting HIV infection. The challenges of this approach include ensuring access and adherence to HIV care and treatment and appropriate prevention activities to ensure adequate and sustained sexual and drug use risk reduction across diverse populations. Experience with approaches to address these issues, particularly in the context of primary care, has been limited. An agenda for future research and practice includes continued development and evaluation of interventions that can address this next generation of health care issues.


Risk Behavior Risk Reduction Sexual Risk Behavior Risk Reduction Counseling Risk Reduction Program 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2003;52:1–24.Google Scholar
  2. 2.
    IOM. No Time to Lose: Getting More from HIV Prevention. Washington, District of Columbia: National Academy of Sciences; 2001.Google Scholar
  3. 3.
    From the Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003. JAMA. 2003;289:2493–2495.CrossRefGoogle Scholar
  4. 4.
    Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, De Cock KM. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health. 2001;91:1019–1024.PubMedGoogle Scholar
  5. 5.
    Crepaz N, Marks G. Towards an understanding of sexual risk behavior in people living with HIV: a review of social, psychological, and medical findings. AIDS. 2002;16:135–149.CrossRefPubMedGoogle Scholar
  6. 6.
    Celentano DD, Munoz A, Cohn S, Nelson KE, Vlahov D. Drug-related behavior change for HIV transmission among American injection drug users. Addiction. 1994;89:1309–1317.CrossRefPubMedGoogle Scholar
  7. 7.
    Celentano DD, Munoz A, Cohn S, Vlahov D. Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users. Drug Alcohol Depend. 2001;61:315–322.CrossRefPubMedGoogle Scholar
  8. 8.
    Schiltz MA, Sandfort TG. HIV-positive people, risk and sexual behaviour. Soc Sci Med. 2000;50:1571–1588.CrossRefPubMedGoogle Scholar
  9. 9.
    Marks G, Burris S, Peterman TA. Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. AIDS. 1999;13:297–306.CrossRefPubMedGoogle Scholar
  10. 10.
    Wilson TE. Sexual and reproductive behavior of women with HIV infection. Clin Obstet Gynecol. 2001;44:289–299.CrossRefPubMedGoogle Scholar
  11. 11.
    Wilson TE, Massad LS, Riester KA, et al. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study. AIDS. 1999;13:591–598.CrossRefPubMedGoogle Scholar
  12. 12.
    Wilson TE, Augenbraun M. Sexually transmitted disease among women with HIV infection: a missed opportunity for intervention. AIDS Read. 1999;9:573–577.PubMedGoogle Scholar
  13. 13.
    Murphy DA, Durako SJ, Moscicki AB, et al. No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. J Adolesc Health. 2001;29:57–63.CrossRefPubMedGoogle Scholar
  14. 14.
    Weinhardt LS, Kelly JA, Brondino MJ, Rotheram-Borus MJ, Kirshenbaum SB, Chesney MA, Remien RH, Morin SF, Lightfoot M, Ehrhardt AA, Johnson MO, Catz SL, Pinkerton SD, Benotsch EG, Hong D, Gore-Felton C; National Institute of Mental Helth Healthy Living Project Team. HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. J Acquir Immune Defic Syndr. 2004;36:1057–1066.PubMedCrossRefGoogle Scholar
  15. 15.
    Kozal MJ, Amico KR, Chiarella J, et al. Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care. AIDS. 2004;18:2185–2189.CrossRefPubMedGoogle Scholar
  16. 16.
    Kalichman SC, Rompa D, Luke W, Austin J. HIV transmission risk behaviours among HIV-positive persons in serodiscordant relationships. Int J STD AIDS. 2002;13:677–682.CrossRefPubMedGoogle Scholar
  17. 17.
    Remien RH, Wagner G, Dolezal C, Carballo-Diaguez A. Factors associated with HIV sexual risk behavior in male couples of mixed HIV status. J Psychol Human Sex. 2001;13:31–48.CrossRefGoogle Scholar
  18. 18.
    Absalon J, Della-Latta P, Wu F, El-Sadr WM. Sexual behaviors and condom use of HIV-infected men and women of color attending a treatment and care clinic. J Natl Med Assoc. 2005;97:25S–31S.PubMedGoogle Scholar
  19. 19.
    van der Straten A, Gomez CA, Saul J, Quan J, Padian N. Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy. AIDS. 2000;14:F47–F54.CrossRefPubMedGoogle Scholar
  20. 20.
    Valdiserri RO. HIV/AIDS stigma: an impediment to public health. Am J Public Health. 2002;92:341–342.PubMedGoogle Scholar
  21. 21.
    Herek GM, Capitanio JP, Widaman KF. HIV-related stigma and knowledge in the United States: prevalence and trends, 1991–1999. Am J Public Health. 2002;92:371–377.PubMedCrossRefGoogle Scholar
  22. 22.
    Aranda-Naranjo B. Quality of life in the HIV-positive patient: implications and consequences. J Assoc Nurses AIDS Care. 2004;15:20S–27S.CrossRefPubMedGoogle Scholar
  23. 23.
    Lansky A, Thomas JC, Earp JA. Partner-specific sexual behaviors among persons with both main and other partners. Fam Plann Perspect. 1998;30:93–96.PubMedCrossRefGoogle Scholar
  24. 24.
    Tun W, Gange SJ, Vlahov D, Strathdee SA, Celentano DD. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clin Infect Dis. 2004;38:1167–1174.CrossRefPubMedGoogle Scholar
  25. 25.
    Wilson TE, Gore ME, Greenblatt R, et al. Changes in sexual behavior among HIV-infected women after initiation of HAART. Am J Public Health. 2004;94:1141–1146.PubMedGoogle Scholar
  26. 26.
    Vlahov D, Safaien M, Lai S, et al. Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS. 2001;15:2311–2316.CrossRefPubMedGoogle Scholar
  27. 27.
    Stolte IG, de Wit JB, van Eeden A, Coutinho RA, Dukers NH. Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV-infected homosexual men. AIDS. 2004;18:1943–1949.CrossRefPubMedGoogle Scholar
  28. 28.
    Stolte IG, Dukers NH, Geskus RB, Coutinho RA, de Wit JB. Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS. 2004;18:303–309.CrossRefPubMedGoogle Scholar
  29. 29.
    Ostrow DE, Fox KJ, Chmiel JS, et al. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS. 2002;16:775–780.CrossRefPubMedGoogle Scholar
  30. 30.
    van der Snoek EM, de Wit JB, Mulder PG, van der Meijden WI. Incidence of sexually transmitted diseases and HIV infection related to perceived HIV/AIDS threat since highly active antiretroviral therapy availability in men who have sex with men. Sex Transm Dis. 2005;32:170–175.CrossRefPubMedGoogle Scholar
  31. 31.
    Tun W, Celentano DD, Vlahov D, Strathdee SA. Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS. 2003;17:1953–1962.CrossRefPubMedGoogle Scholar
  32. 32.
    Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. 2004;292:224–236.CrossRefPubMedGoogle Scholar
  33. 33.
    Remien RH, Halkitis PN, O'Leary A, Wolitski RJ, Gomez CA. Risk perception and sexual risk behaviors among HIV-positive men on antiretroviral therapy. AIDS Behav. 2005;9:167–176.CrossRefPubMedGoogle Scholar
  34. 34.
    Remien RH, Hirky AE, Johnson MO, Weinhardt LS, Whittier D, Le GM. Adherence to medication treatment: a qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four US cities. AIDS Behav. 2003;7:61–72.CrossRefPubMedGoogle Scholar
  35. 35.
    Sethi AK, Celentano DD, Gange SJ, Gallant JE, Vlahov D, Farzadegan H. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. J Acquir Immune Defic Syndr. 2004;35:503–510.PubMedCrossRefGoogle Scholar
  36. 36.
    Hosseinipour M, Cohen MS, Vernazza PL, Kashuba AD. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis. 2002;34:1391–1395.CrossRefPubMedGoogle Scholar
  37. 37.
    Vernazza PL, Troiani L, Flepp MJ, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS. 2000;14:117–121.CrossRefPubMedGoogle Scholar
  38. 38.
    Taylor S, Boffito M, Vernazza PL. Antiretroviral therapy to reduce the sexual transmission of HIV. J HIV Ther. 2003;8:55–66.PubMedGoogle Scholar
  39. 39.
    Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003;37:1112–1118.CrossRefPubMedGoogle Scholar
  40. 40.
    Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMedGoogle Scholar
  41. 41.
    McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis. 2001;33:700–705.CrossRefPubMedGoogle Scholar
  42. 42.
    Giron-Gonzalez JA, Lopez-Sanchez A, Elvira J, Perez E, Fernandez-Gutierrez C. Effect of patient adherence to antiretroviral therapy on CD4+ cell count, HIV-1 RNA, and serum concentrations of tumor necrosis factor and its soluble receptors. Eur J Clin Microbiol Infect Dis. 2000;19:852–858.CrossRefPubMedGoogle Scholar
  43. 43.
    Low-Beer S, Yip B, O'Shaughnessy MV, Hogg RS, Montaner JS. Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr. 2000;23:360–361.PubMedGoogle Scholar
  44. 44.
    Wilson TE, Barron Y, Cohen M, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002;34:529–534.CrossRefPubMedGoogle Scholar
  45. 45.
    Flaks RC, Burman WJ, Gourley PJ, Rietmeijer CA, Cohn DL. HIV transmission risk behavior and its relation to antiretroviral treatment adherence. Sex Transm Dis. 2003;30:399–404.PubMedCrossRefGoogle Scholar
  46. 46.
    Kalichman SC, Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex Transm Infect. 2003;79:59–61.CrossRefPubMedGoogle Scholar
  47. 47.
    Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S123–S127.PubMedGoogle Scholar
  48. 48.
    Palepu A, Horton NJ, Tibbetts N, Meli S, Samet JH. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction. 2004;99:361–368.CrossRefPubMedGoogle Scholar
  49. 49.
    Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38:432–438.CrossRefPubMedGoogle Scholar
  50. 50.
    Lucas GM, Flexner CW, Moore RD. Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden? AIDS Patient Care STDs. 2002;16:527–535.CrossRefPubMedGoogle Scholar
  51. 51.
    Greenberg B, Berkman A, Thomas R, et al. Evaluating supervised HAART in late-stage HIV among drug users: a preliminary report. J Urban Health. 1999;76:468–480.CrossRefPubMedGoogle Scholar
  52. 52.
    Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11:185–198.PubMedGoogle Scholar
  53. 53.
    Blackard JT, Mayer KH. HIV superinfection in the era of increased sexual risk-taking. Sex Transm Dis. 2004;31:201–204.PubMedCrossRefGoogle Scholar
  54. 54.
    Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3–17.PubMedGoogle Scholar
  55. 55.
    Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921–929.CrossRefPubMedGoogle Scholar
  56. 56.
    Kalichman SC, Rompa D, Cage M. Group intervention to reduce HIV transmission risk behavior among persons living with HIV/AIDS. Behav Modif. 2005;29:256–285.CrossRefPubMedGoogle Scholar
  57. 57.
    Kalichman SC, Rompa D, Cage M, et al. Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. Am J Prev Med. 2001;21:84–92.CrossRefPubMedGoogle Scholar
  58. 58.
    Kelly JA, McAuliffe TL, Sikkema KJ, et al. Reduction in risk behavior among adults with severe mental illness who learned to advocate for HIV prevention. Psychiatr Serv. 1997;48:1283–1288.PubMedGoogle Scholar
  59. 59.
    Richardson JL, Milam J, McCutchan A, et al. Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: a multi-clinic assessment. AIDS. 2004;18:1179–1186.CrossRefPubMedGoogle Scholar
  60. 60.
    Wingood GM, DiClemente RJ, Mikhail I, et al. A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program. J Acquir Immune Defic Syndr. 2004;37:S58–S67.PubMedCrossRefGoogle Scholar
  61. 61.
    Wyatt GE, Longshore D, Chin D, et al. The efficacy of an integrated risk reduction intervention for HIV-positive women with child sexual abuse histories. AIDS Behav. 2004;8:453–462.CrossRefPubMedGoogle Scholar
  62. 62.
    Rotheram-Borus MJ, Lee MB, Murphy DA, et al. Efficacy of a preventive intervention for youths living with HIV. Am J Public Health. 2001;91:400–405.PubMedGoogle Scholar
  63. 63.
    Patterson TL, Shaw WS, Semple SJ. Reducing the sexual risk behaviors of HIV+ individuals: outcome of a randomized controlled trial. Ann Behav Med. 2003;25:137–145.CrossRefPubMedGoogle Scholar
  64. 64.
    Gordon CM, Forsyth AD, Stall R, Cheever LW. Prevention interventions with persons living with HIV/AIDS: state of the science and future directions. AIDS Educ Prev. 2005;17:6–20.CrossRefPubMedGoogle Scholar
  65. 65.
    Marks G, Richardson JL, Crepaz N, et al. Are HIV care providers talking with patients about safer sex and disclosure? A multi-clinic assessment. AIDS. 2002;16:1953–1957.CrossRefPubMedGoogle Scholar
  66. 66.
    Metsch LR, Pereyra M, del Rio C, et al. Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities. Am J Public Health. 2004;94:1186–1192.PubMedGoogle Scholar
  67. 67.
    Fishbein M, Bandura A, Triandis HC, et al. Factors influencing behavior and behavior change: final report—Theorist’s workshop. In: Baum A, Revenson T, Singer J, eds. Handbook of Health Psychology. New Jersey: Lawrence Erlbaum and Associates; 2001.Google Scholar
  68. 68.
    Fishbein M, Ajzen I. Attitude, Intention, and Behavior: An Introduction to Theory and Research. Reading, Massachusetts: Addison-Wesley; 1975.Google Scholar
  69. 69.
    Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv. 2002;53:868–873.CrossRefPubMedGoogle Scholar
  70. 70.
    Walkup J, Crystal S, Sambamoorthi U. Schizophrenia and major affective disorder among Medicaid recipients with HIV/AIDS in New Jersey. Am J Public Health. 1999;89:1101–1103.PubMedGoogle Scholar
  71. 71.
    Remien RH, Johnson JG. Psychiatric disorders and symptoms associated with sexual risk behavior. Psychiatric Times. 2004; 21.Google Scholar
  72. 72.
    Stein M, Herman DS, Trisvan E, Pirraglia P, Engler P, Anderson BJ. Alcohol use and sexual risk behavior among human immunodeficiency virus-positive persons. Alcohol Clin Exp Res. 2005;29:837–843.CrossRefPubMedGoogle Scholar
  73. 73.
    Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–728.CrossRefPubMedGoogle Scholar
  74. 74.
    Sambamoorthi U, Walkup J, Olfson M, Crystal S. Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression. J Gen Intern Med. 2000;15:311–320.CrossRefPubMedGoogle Scholar
  75. 75.
    Sambamoorthi U, Warner LA, Crystal S, Walkup J. Drug abuse, methadone treatment, and health services use among injection drug users with AIDS. Drug Alcohol Depend. 2000;60:77–89.CrossRefPubMedGoogle Scholar
  76. 76.
    Palepu A, Raj A, Horton NJ, Tibbetts N, Meli S, Samet JH. Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems. J Subst Abuse Treat. 2005;28:3–9.CrossRefPubMedGoogle Scholar
  77. 77.
    Klinkenberg WD, Sacks S. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16(Suppl 1):S22–S42.CrossRefPubMedGoogle Scholar
  78. 78.
    Klein SJ, Cruz H, O'Connell DA, Scully MA, Birkhead GS. A public health approach to “prevention with positives”: the New York State HIV/AIDS Service Delivery System. JPublic Health Manag Pract. 2005;11:7–17.PubMedGoogle Scholar
  79. 79.
    Vlahov D, Galai N, Safaeian M, et al. Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodeficiency virus infection. Am J Epidemiol. 2005;161:999–1012.CrossRefPubMedGoogle Scholar
  80. 80.
    Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38:445–448.CrossRefPubMedGoogle Scholar
  81. 81.
    Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19–S25.CrossRefPubMedGoogle Scholar
  82. 82.
    Richman DD, Morton SC, Wrin T, et al. The prevalence of antiretroviral drug resistance in the United States. AIDS. 2004;18:1393–1401.CrossRefPubMedGoogle Scholar
  83. 83.
    Kresina TF, Flexner CW, Sinclair J, et al. Alcohol use and HIV pharmacotherapy. AIDS Res Hum Retroviruses. 2002;18:757–770.CrossRefPubMedGoogle Scholar
  84. 84.
    Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352:570–585.CrossRefPubMedGoogle Scholar
  85. 85.
    Celentano DD, Galai N, Sethi AK, et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS. 2001;15:1707–1715.CrossRefPubMedGoogle Scholar
  86. 86.
    Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191:1403–1409.CrossRefPubMedGoogle Scholar
  87. 87.
    Pealer LN, Peterman TA. When it comes to contact notification, HIV is not TB. Int J Tuberc Lung Dis. 2003;7:S337–S341.PubMedGoogle Scholar
  88. 88.
    High-risk sexual behavior by HIV-positive men who have sex with men—16 sites, United States, 2000–2002. MMWR Morb Mortal Wkly Rep. 2004;53:891–894.Google Scholar
  89. 89.
    Del Rio C. New challenges in HIV care: prevention among HIV-infected patients. Top HIV Med. 2003;11:140–144.PubMedGoogle Scholar
  90. 90.
    Morin SF, Koester KA, Steward WT, et al. Missed opportunities: prevention with HIV-infected patients in clinical care settings. J Acquir Immune Defic Syndr. 2004;36:960–966.PubMedCrossRefGoogle Scholar
  91. 91.
    Myers JJ, Steward WT, Charlebois E, Koester KA, Maiorana A, Morin SF. Written clinic procedures enhance delivery of HIV “Prevention with Positives” counseling in primary health care settings. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S95–S100.PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Tracey E. Wilson
    • 1
    Email author
  • David Vlahov
  • Stephen Crystal
  • Judith Absalon
  • Susan J. Klein
  • Robert H. Remein
  • Bruce Agins
  1. 1.HIV Center for Women and Children, Department of Preventive Medicine and Community HealthState University of New York, Downstate Medical CenterBrooklynUSA

Personalised recommendations